![Shiro Mita](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Shiro Mita
Fondateur chez M's Science Corp.
Profil
Shiro Mita is the founder of M's Science Corp.
established in 2000, where he holds the title of Representative Director.
Dr. Mita obtained a doctorate degree from the University of Tokyo.
Postes actifs de Shiro Mita
Sociétés | Poste | Début |
---|---|---|
M's Science Corp.
![]() M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Fondateur | 01/11/2000 |
Anciens postes connus de Shiro Mita
Sociétés | Poste | Fin |
---|---|---|
KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Directeur/Membre du Conseil | - |
SANTEN PHARMACEUTICAL CO., LTD. | Directeur/Membre du Conseil | - |
ACUCELA INC | Directeur/Membre du Conseil | - |
Keio University | Corporate Officer/Principal | - |
Formation de Shiro Mita
University of Tokyo | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
Entreprise privées | 2 |
---|---|
Acucela, Inc.
![]() Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
M's Science Corp.
![]() M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Commercial Services |